Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease

American Journal of Cardiology

Volumn 112, Issue 2, 2013, Pages 255-259

  Bakris, George ^a   Briasoulis, Alexandros ^a   Dahlof, Bjorn ^b   Jamerson, Kenneth ^c   Weber, Michael A ^d   Kelly, Roxzana Y ^e   Hester, Allen ^e   Hua, Tsushung ^e   Zappe, Dion ^e   Pitt, Bertram ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROCHLOROTHIAZIDE;

ADULT; ALLERGIC REACTION; ANGIONEUROTIC EDEMA; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COUGHING; DIABETES MELLITUS; DIZZINESS; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERIPHERAL EDEMA; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BENZAZEPINES; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84879841011     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.03.026     Document Type: Article

References (14)

1. K. Jamerson, M.A. Weber, G.L. Bakris, B. Dahlof, B. Pitt, V. Shi, A. Hester, J. Gupte, M. Gatlin, and E.J. Velazquez Benazepril plus amlodipine or hydrochloro-thiazide for hypertension in high-risk patients N Engl J Med 359 2008 2417 2428
2. K.A. Jamerson, G.L. Bakris, and M.A. Weber 24-Hour ambulatory blood pressure in the ACCOMPLISH trial N Engl J Med 363 2010 98
3. S.K. Chugh, K. Digpal, T. Hutchinson, C.J. McDonald, A.J. Miller, and A. Lahiri A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina J Cardiovasc Pharmacol 38 2001 356 364
4. R. Hall, and C. Chong A double-blind, parallel-group study of amlodipine versus long-acting nitrate in the management of elderly patients with stable angina Cardiology 96 2001 72 77
5. M.A. Weber, G.L. Bakris, B. Dahlof, B. Pitt, E. Velazquez, J. Gupte, M. Lefkowitz, A. Hester, V. Shi, M. Weir, S. Kjeldsen, B. Massie, S. Nesbitt, E. Ofili, and K. Jamerson Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk Blood Press 16 2007 13 19
6. K.A. Jamerson, G.L. Bakris, C.C. Wun, B. Dahlof, M. Lefkowitz, S. Manfreda, B. Pitt, E.J. Velazquez, and M.A. Weber Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension Am J Hypertens 17 2004 793 801
7. S.J. Brener, T.B. Ivanc, R. Poliszczuk, M. Chen, E.M. Tuzcu, T. Hu, D.J. Frid, and S.E. Nissen Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials Am Heart J 152 2006 1059 1063
8. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
9. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
10. C. Ceconi, K.M. Fox, W.J. Remme, M.L. Simoons, M. Bertrand, G. Parrinello, C. Kluft, A. Blann, D. Cokkinos, and R. Ferrari ACE inhibition with perindopril and endothelial function: results of a substudy of the EUROPA study: PERTINENT Cardiovasc Res 73 2007 237 246
11. H.M. Siragy, C. Xue, and R.L. Webb Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia J Cardiovasc Pharmacol 47 2006 636 642
12. H.M. Siragy Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin- aldosterone system blockers J Hypertens 28 2010 2 8
13. B. Williams, P.S. Lacy, S.M. Thom, K. Cruickshank, A. Stanton, D. Collier, A.D. Hughes, H. Thurston, and M. O'Rourke Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study Circulation 113 2006 1213 1225
14. D. Bassler, M. Briel, V.M. Montori, M. Lane, P. Glasziou, Q. Zhou, D. Heels-Ansdell, S.D. Walter, G.H. Guyatt, D.N. Flynn, M.B. Elamin, M.H. Murad, N.O. Abu Elnour, J.F. Lampropulos, A. Sood, R.J. Mullan, P.J. Erwin, C.R. Bankhead, R. Perera, C. Ruiz Culebro, J.J. You, S.M. Mulla, J. Kaur, K.A. Nerenberg, H. Schunemann, D.J. Cook, K. Lutz, C.M. Ribic, N. Vale, G. Malaga, E.A. Akl, I. Ferreira-Gonzalez, P. Alonso-Coello, G. Urrutia, R. Kunz, H.C. Bucher, A.J. Nordmann, H. Raatz, S.A. da Silva, F. Tuche, B. Strahm, B. Djulbegovic, N.K. Adhikari, E.J. Mills, F. Gwadry-Sridhar, H. Kirpalani, H.P. Soares, P.J. Karanicolas, K.E. Burns, P.O. Vandvik, F. Coto-Yglesias, P.P. Chrispim, and T. Ramsay Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis JAMA 303 2010 1180 1187